Skip to main content
Log in

Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: Effect of secoisolariciresinol diglucoside (SDG)

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Secoisolariciresinol diglucoside (SDG) isolated from flaxseed has antioxidant activity and has been shown to prevent hypercholesterolemic atherosclerosis. An investigation was made of the effects of SDG on the development of diabetes in diabetic prone BioBreeding rats (BBdp rats), a model of human type I diabetes [insulin dependent diabetes mellitus (IDDM)] to determine if this type of diabetes is due to oxidative stress and if SDG can prevent the incidence of diabetes. The rats were divided into three groups: Group I, BioBreeding normal rats (BBn rats) (n = 10); group II, BBdp untreated (n = 11); and group III, BBdp treated with SDG 22 mg/kg body wt, orally) (n = 14). Oxidative stress was determined by measuring lipid peroxidation product malondialdehyde (MDA) an index of level of reactive oxygen species in blood and pancreas; and pancreatic chemiluminescence (Pancreatic-CL), a measure of antioxidant reserve. Incidence of diabetes was 72.7% in untreated and 21.4% in SDG-treated group as determined by glycosuria and hyperglycemia. SDG prevented the development of diabetes by approximately 71%. Development of diabetes was associated with an increase in serum and pancreatic MDA and a decrease in antioxidant reserve. Prevention in development of diabetes by SDG was associated with a decrease in serum and pancreatic-MDA and an increase in antioxidant reserve. These results suggest that IDDM is mediated through oxidative stress and that SDG prevents the development of diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nerup J: HLA studies in diabetes mellitus. A Review. Adv Metab Disord 9: 263-273, 1978

    Google Scholar 

  2. Rayfield EJ, Kelly KJ, Yoon JW: Rubella virus-induced diabetes in hamster. Diabetes 35: 1276-1281, 1986

    Google Scholar 

  3. Ginsberg-Fellener F, Witt ME, Yagihashi S, Dobersen MJ, Taub F, Fedun B, McCoy RC, Roman SH, Davies TF, Cooper LZ, Rubenstein P, Notteins AL: Congenital rubella syndrome as a model for Type I (insulin-dependent) diabetes mellitus: Increased prevalance of islet cell surface antibodies. Diabetologia 27: 87-89, 1984

    Google Scholar 

  4. Rabinovitch A, Suarez WL, Thomas PD, Strynadka K, Simpson I: Cytotoxic effects of cytokines on rat islets: Evidence for involvement of free radicals and lipid peroxidation. Diabetologia 35: 409-413, 1992

    Google Scholar 

  5. Dulin WE, Soret MG: Chemically and hormonally induced diabetes. In: M.E. Volk, K.F. Wellman (eds). The Diabetic Pancreas. Plenum Press, New York, 1977, pp 425-465

    Google Scholar 

  6. Junod A, Lambert AE, Orci L, Pictet R, Gonent AE, Renold AE: Studies of the diabetogenic action of streptozotocin. Pro Soc Expt Biol Med 126: 201-205, 1967

    Google Scholar 

  7. Barbosa J, Bach FH: Cell mediated autoimmunity in Type I diabetes. Diabetes Metab Rev 3: 981-1004, 1987

    Google Scholar 

  8. Charlton BA, Bacelj A, Mandel TE: Administration of silica particles or anti Lyt 2 antibody prevents beta-cell destruction in mice given cyclophosphamide. Diabetes 37: 930-935, 1988

    Google Scholar 

  9. Nathan CF, Tsunawaki S: Secretion of toxic oxygen products by macrophages: Regulatory cytokines and their effects on the oxidase. Ciba Foundation Symposium 118: 211-230, 1986

    Google Scholar 

  10. Berton G, Zeni L, Cassatella MA, Rossi F: Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem Biophys Res Commun 138: 1276-1282, 1986

    Google Scholar 

  11. Braquet P, Hosfard D, Braquet M, Bourgain R, Bussolino F: Role of cytokines and platelet activating factor in microvascular injury. Int Arch Allerg Appl Immunol 88: 88-100, 1989

    Google Scholar 

  12. Paubert-Braquet M, Longchamps MA, Kolz P: Tumor necrosis factor (TNF) primes human neutrophil (PMN) platelet-activating factor (PAF)-induced superoxide generation. Consequences in promoting PMN-mediated endothelial cell (EC) damages. Prostaglandins 35: (abstr) 803, 1988

    Google Scholar 

  13. Freeman BA, Crapo JD: Biology of disease. Free radicals and tissue injury. Lab Invest 47: 412-426, 1982

    Google Scholar 

  14. Meerson FZ, Kagan VE, Kozlov YP, Belkina LM, Arkhipenko YV: The role of lipid peroxidation in pathogenesis of ischemic damage and antioxidant protection of the heart. Basic Res Cardiol 77: 465-468, 1982

    Google Scholar 

  15. Sumoski W, Baquerizo H, Rabinovitch A: Oxygen radical scavengers protect rat islet cells from damage by cytokines. Diabetologia 32: 792-796, 1989

    Google Scholar 

  16. Prasad K: Dietary flaxseed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 132: 69-76, 1997

    Google Scholar 

  17. Prasad K, Mantha SV, Muir AD, Westcott ND: Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 136: 367-375, 1998

    Google Scholar 

  18. Kelley DS, Branch LB, Love JE, Taylor PC, Rivera YM, Iacono JM: Dietary alpha-linolenic acid and immunocompetence in humans. Am J Clin Nutr 53: 40-46, 1991

    Google Scholar 

  19. Cox CP, Wood KL: Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion of washed rabbit platelets by (CV-3988, L-652731, trizolam and alphazolam. Thromb Res 47: 249-257, 1987

    Google Scholar 

  20. Westcott ND, Muir AD: Process for extracting lignans from flaxseed. U.S. Patent NO. 5705618, Jan 1988

  21. Prasad K: Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flaxseed. Mol Cell Biochem 168: 117-123, 1997

    Google Scholar 

  22. Mordes JP, Desemone J, Rossini AA: The BB rat Diabetes Metab Rev 3: 725-750, 1987

    Google Scholar 

  23. Prasad K, Gupta JB, Kalra J, Lee P, Mantha SV, Bharadwaj B: Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 28: 375-385, 1996

    Google Scholar 

  24. Kapoor R, Prasad K: Role of oxyradicals in cardiovascular depression and cellular injury in hemorrhagic shock and re-infusion: Effect of SOD and catalase. Circ Shock 43: 79-94, 1994

    Google Scholar 

  25. Prasad K, Kalra J: Oxygen free radicals and hypercholesterolemic atherosclerosis: Effect of vitamin E. Am Heart J 125: 958-973, 1993

    Google Scholar 

  26. Prasad K, Kalra J, Lee P: Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: Effects of Probucol. Int J Angiol 3: 100-112, 1994

    Google Scholar 

  27. Cornall AG, Bardwill CJ, David MM: Determination of serum proteins by means of biuret reaction. J Biol Chem 177: 751-776, 1949

    Google Scholar 

  28. Kadish AH, Little RL, Sternberg JC: A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14: 116-131, 1968

    Google Scholar 

  29. Laupacis A, Gardell C, Dupre J, Stiller CR, Keown P, Wallace AC, Thibert P: Cytosporin prevents diabetes in BB Wistar rats. Lancet I: 10-12, 1983

    Google Scholar 

  30. Lefkowith J, Schreiner G, Cormier J, Handler ES, Driscoll HK, Greiner D, Mordes JP, Rossini AA: Prevention of diabetes in the BB rat by essential fatty acid deficiency: Relationship between physiological and biochemical changes. J Exp Med 171: 729-743, 1990

    Google Scholar 

  31. Prasad K: Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside (SDG) isolated from flaxseed. Circulation 99: 1355-1362, 1999

    Google Scholar 

  32. Jain SK, Levine SN, Duett J, Hollier B: Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats. Metabolism 39: 971-975, 1990

    Google Scholar 

  33. Kakkar R, Kalra J, Mantha SV, Prasad K: Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol Cell Biochem 151: 113-119, 1995

    Google Scholar 

  34. Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J: Increased oxidative stess in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci 94: 623-632, 1998

    Google Scholar 

  35. Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnet AH: Increased diene conjugates in diabetic subjects with micoroangiopathy. Diabetic Med 4: 452-456, 1987

    Google Scholar 

  36. Godin DV, Wohaeib SA, Garnett ME, Goumeniouk AD: Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem 84: 223-231, 1988

    Google Scholar 

  37. Hunt JV, Smith CCT, Wolff SP: Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39: 420-424, 1990

    Google Scholar 

  38. Wolff SP, Dean RT: Glucose autoxidation and protein modification, the potential role of autoxidative glycosylation in diabetes. Biochem J 245: 243-250, 1987

    Google Scholar 

  39. Cadenas E, Sies H: Low level chemiluminescence of liver microsomal fractions initiated by tert-butyl hydroperoxide: relation to microsomal hemoproteins, oxygen dependence, and lipid peroxidation. Eur J Biochem 124: 349-356, 1982

    Google Scholar 

  40. Cadenas E, Varsavsky AI, Boveris A, Chance B: Oxygen or organic hydroperoxide-induced chemiluminescence of brain and liver homogenates. Biochem J 198: 645-654, 1981

    Google Scholar 

  41. Cadenas E, Wefers H, Sies H: Low level chemiluminescence of isolated hepatocytes. Eur J Biochem 119: 531-536, 1981

    Google Scholar 

  42. Grankvist K, Marklund S, Sehlin J, Teljedal IB: Superoxide dismutase, catalase and scavengers of hydorxyl radicals protect against the toxic action of alloxan on pancreatic islet cells in vitro. Biochem J 182: 17-25, 1979

    Google Scholar 

  43. Mclennan SV, Heffernen S, Wright l, Rae C, Fisher E, Yue OK, Turtle JR: Changes in hepatic glutathione metabolites in diabetes. Diabetes 40: 344-348, 1991

    Google Scholar 

  44. Murakami R, Knodo T, Ohtsuka Y, Fijiwara Y, Shimada M, Kaloakame Y: Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 38: 753-758, 1989

    Google Scholar 

  45. Asplund K, Grankvist K, Marklund S, Taljedal LB: Partial protection against streptozotocin induced hyperglycemia by superoxide dismutase linked to polyethlyene glycol. Acta Endocrinol 107: 390-394, 1984

    Google Scholar 

  46. Young IS, Tate S, Lightbody JH, McMaster D, Trimble ER: The effects of desferrioxamine and ascorbate on oxidative stress in streptozotosin diabetic rat. Free Radic Biol Med 18: 833-840, 1995

    Google Scholar 

  47. Gorsch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG: Evidence for a long prediabetic period in Type I (insulin dependent) diabetes mellitus. Lancet ii: 1363-1366, 1981

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prasad, K. Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: Effect of secoisolariciresinol diglucoside (SDG). Mol Cell Biochem 209, 89–96 (2000). https://doi.org/10.1023/A:1007079802459

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007079802459

Navigation